Home This healthtech start-up that delivers more accurate drug doses has raised a $2.6m Series A round at a $20m valuation medical

medical

DoseMe founder Dr Robert McLeay, Steve Baxter, DoseMe CEO Charles Cornish and DoseMe Series A investor Greg Spurgin
The DoseMe team Dr Robert McLeay and Charles Cornish
Subscribe to the Newsletter Over 30K subscribers

FREE BUSINESS TOOLS

FREE BUSINESS TOOL

Inbound Marketing Reloaded with James Tuckerman [FREE REPORT]

Leads always must come before sales. Then, it’s your job to build trust, educate, create rapport and demonstrate why your product and service is better than the alternatives. However, the tools at your disposal to achieve these outcomes -- to connect with strangers, to convert them to suspects, then prospects, then customers -- are constantly changing. That’s why we created this cheat sheet. To re-visit traditional inbound marketing strategies, and offer some helpful tactics to help ‘old school’ organisations embrace ‘new world’ tactics and strategies.

INFOGRAPHICS

New Zealand’s Xero eyes US IPO, further disruption as subscribers increase...

Xero recently held its annual meeting in Wellington, during which the company revealed some interesting details about its future. As has been widely suspected, the...

OPINIONS & ADVICE